Life Sciences Portfolio

AneuRx

Stent grafts for abdominal aortic aneurysm

Acquired by Medtronic
(MDT)
Arbor Health Care

Skilled nursing and subacute care centers

Acquired by Extendicare
(EXE)
Ardian

Catheter-based treatment for hypertension

Acquired by Medtronic
Athena Neurosciences

Pharmaceuticals for neurological diseases

Acquired by Elan Corp., plc
(ELN)
Avidia

New protein structural motifs for treating human disease.

Acquired by Amgen
(AMGN)
Cabochon Aesthetics

A medical device company developing effective scientific solutions for aesthetic procedures.

PRIVATE
Calithera Biosciences

A new class of anti-cancer therapeutics based on activation of caspases
Cardiomind, Inc.

Stents for small diameter and distal hard-to-reach coronary vessels.

PRIVATE
CardioThoracic Systems

Devices for minimally-invasive heart surgery

Acquired by Guidant
(GDT)
CareMedic

Revenue cycle management systems for hospitals

PRIVATE
Catalyst Biosciences

Developer of engineered proteases as protein therapeutics that attack targets which cause disease.

PRIVATE
Coalescent Surgical

Devices for automating tissue attachment

PRIVATE
Elcelyx Therapeutics

Elcelyx is a biotechnology company that is creating new therapeutics for the treatment of diabetes and obesity
Embol-X

Devices to protect the brain from stroke

Acquired by Edwards Lifesciences
(EW)
FoldRx Pharmaceuticals

Treatments for diseases caused by misfolding of specific proteins

Acquired by Pfizer
ForSight Labs

Ophthalmic incubator creating unique solutions that address unmet clinical needs in diseases of the eye.

PRIVATE
ForSight Vision4

Developer of innovative drug delivery platform for ophthalmic use
ForSight Vision5

Developing novel device solutions for ophthalmic diseases
Galleon Pharmaceuticals

Innovative medicines for pulmonology, neurology, cardiology, sleep medicine and pediatrics

PRIVATE
Gliatech

Devices for the treatment of the nervous system

(GLIA)
GlobeImmune

Therapeutic vaccine platform technology targeting infectious disease and cancer

PRIVATE
HolairaNovel devices for treating lung diseases
Intact Medical

Develops minimally invasive RF-based surgical instruments for biopsy

PRIVATE
IPC – The Hospitalist Company

Hospital-based physician practice management company

(IPCM)
Kona Medical

Develops a novel, non-invasive technology for the treatment of hypertension (HTN)
LuMend

Devices for treating chronic total occlusions

PRIVATE
Medaphis

Business management services for hospitals/physicians

Acquired by Per-Sé
(PSTI)
Miramar

Device for the treatment of hyperhidrosis and aesthetic complications of excessive sweating

PRIVATE
Morphotek, Inc.

Next generation antibodies production technology.

Acquired by EISIA
Mosaic Biosciences

Platform for tissue engineering using synthetic smart polymers
Moximed

An innovative treatment for patients with osteoarthritis

PRIVATE
NeuroControl

Devices for the treatment of neuromuscular disorders

PRIVATE
Nexis Vision

Developer of ophthalmic device to reduce post-refractive surgery pain and improve visual acuity
OncoMed Pharmaceuticals Inc.

Biological therapeutics targeting cancer stem cells

PRIVATE
Optiscan Biomedical Corporation

Instruments and sensors for accurate, automated measurement of blood glucose levels

PRIVATE
Orexigen

Developer of drug treatments for obesity and related disorders.

(OREX)
Perclose

Suture-mediated vascular closure systems

Acquired by Abbott Labs
(ABT)
Principia

Drug discovery company based on a proprietary chemistry platform that generates novel compounds with enhanced selectivity, high potency and longer duration of effect
Promedior Pharmaceuticals

Therapeutics to treat fibrosis

PRIVATE
Ra Pharmaceuticals

Platform for orally available and cell permeable biologics
Relievant Medsystems

Relievant Medsystems is developing a treatment for lower back pain

PRIVATE
Replidyne

Drug discovery and development focused on a new class of antibiotics

(RDYN)
Ribozyme Pharmaceuticals

RNA-based pharmaceuticals for human disease

(RZYM)
Second Genome

Microbiome-based therapeutics for infection, inflammation, and metabolic disease
Sequana Therapeutics

Gene discovery via functional genomics

Acquired by Axys Pharmaceutical
(AXPH)
SetPoint Medical

Neuro-modulation platform for the treatment of a variety of acute and chronic diseases

PRIVATE
SONIC innovations

Digital hearing aids

(SNCI)
Spine Wave, Inc.

Novel devices for spine surgery

PRIVATE
Stemgent

Reagents for stem cell researchers

PRIVATE
The Foundry

Medical device incubator

PRIVATE
Thermage

Devices for cosmetic aesthetic surgery

(THRM)
Third Millenium Healthcare Systems

Internet-based workflow solutions for healthcare organizations

Merged with CareMedic
Threshold Pharmaceutical, Inc.

Developing targeted therapies for treatment of cancer.

(THLD)
Tragara Pharmaceuticals

Developer of drugs for the treatment of cancer and inflammation-related diseases.

PRIVATE
Transcend

Ophthalmic devices for diseases of the eye

PRIVATE
Trellis Bioscience

Platform technology for monoclonal antibody development and production

PRIVATE
Twelve

Developing a novel device for treatment of chronic cardiovascular diseases

PRIVATE
VertiflexImplantable devices for treatment of chronic spinal disorders

PRIVATE
Vical

DNA-based pharmaceuticals for human disease

(VICL)
XTENT

Next-generation products designed to increase the market penetration of stents

(XTNT)

Links to other Web sites found here are provided to assist you in locating information. Morgenthaler is not responsible for the content of the Web sites found at these links, or beyond, and does not attest to the accuracy, completeness or timeliness of the information they contain. In addition, we have highlighted a select number portfolio companies on a number of our Web pages, but encourage you to review our entire portfolio listed in our Portfolio tabs.